from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2179c/-

LFCtreatmentdescriptionclass of inhibitor

-0.204

Amikacinug/mL Amikacintranslation

0.086

Cap5-10ug/mL Capreomycintranslation

-0.510

Rox10-50 ug/mL Roxithromycintranslation

0.374

SM2-5 ug/mL Streptomycintranslation

-0.125

Tet5-10 ug/mL Tetracyclinetranslation

0.705

Rif0.2-5ug/mL Rifampicintranscription

0.753

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.366

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.172

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.472

CPZ10-50 ug/mL Chlorpromazinerespiration

0.307

Clofazimine10-13 ug/mL Clofaziminerespiration

0.310

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.326

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.189

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.044

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.156

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.437

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.205

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.024

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.062

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.471

KCN5-20 ug/mL Potassium cyaniderespiration

0.591

NaN30.2-2 mM Sodium aziderespiration

0.247

Nigericin50 uM Nigericinrespiration

0.765

TRC10-150 ug/mL Triclosanrespiration

1.018

TRZ10-25 ug/mL Thioridazinerespiration

-0.027

Valinomycin0.5-10 uM Valinomycinrespiration

1.865

ZnSO42 mM ZnSO4respiration

-0.433

menadione6-10 ug/mL Menadionerespiration

0.439

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.116

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.940

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.528

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.355

NRP_1Non-replicating persistence stage 1dosRassociated

-0.427

Amp0.2mg/mL AmpicillincellWall

0.396

Cephalexin20-100 ug/mL CephalexincellWall

0.032

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.503

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.228

EMB10-20 ug/mL EthambutolcellWall

-0.120

Eta12-40 ug/mL EthionamidecellWall

-0.248

INH0.2-0.4 ug/mL IsoniazidcellWall

0.157

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.017

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.089

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.668

BZA0.12 mg/mL BenzamidearomaticAmides

-0.608

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.791

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.342

H2O24 mM hydrogen peroxideDNAdamaging

0.283

Levo10 ug/mL LevofloxacinDNAdamaging

-0.535

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.934

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.084

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.180

UVUV-irradiationDNAdamaging

0.864

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.260

Antimycin12.5-50 ug/mL Antimycin A?

0.373

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.206

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.160

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.683

PA8240.2-2 ug/mL PA-824?

0.098

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.251

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.812

Verapamil50 uM Verapamil?

-0.072

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.361

methoxatin10-20 ug/mL Methoxatin?